突发性感音神经性聋的类固醇治疗:CHEER网络研究
该研究基于CHEER网络117例接受类固醇治疗的突发性感音神经性聋患者,比较口服、鼓室内及联合给药模式的效果。结果显示57%患者自报改善,但听力学与言语测试改善未达统计学显著性,且不同给药方式间无显著差异。样本量小可能限制疗效区分。
要点
- 口服与口服+鼓室内联合组样本量足以统计比较,两组改善无显著差异。
- 57%患者自报改善(轻微或显著),但听力学与言语测试改善未达统计学显著性。
- 样本量小可能阻碍不同类固醇给药方式疗效的区分。
核心结论
- 多数接受类固醇治疗的患者听力有改善,但未达统计学显著性标准。
- 不同给药方式(口服 vs 口服+鼓室内)之间改善程度无显著差异。
- 样本量较小可能限制了疗效差异的检出。
研究设计与样本
- 横断面重复测量研究,患者来自CHEER网络(30个社区与学术耳鼻咽喉科实践点)。
- 从更大规模CHEER网络临床实践指南依从性研究中招募117例因突发性感音神经性聋接受类固醇治疗的患者。
- 结局包括听力学与言语评分及患者感知改善,采用描述性分析、Wilcoxon秩和检验和Fisher精确检验。
主要发现
- 口服与同时口服+鼓室内两类给药组样本量足以进行统计比较。
- 听力学与言语测试评分均见改善。
- 57%患者自报改善为轻微或显著。
- 两类给药组间改善程度无显著差异。
关键数值与推荐
- 57%患者自报改善(轻微或显著)。
- 口服与口服+鼓室内组间改善程度无显著差异。
临床怎么用
- 类固醇治疗突发性感音神经性聋时,口服与联合鼓室内给药均可考虑,但需注意证据未显示显著差异。
- 临床决策应结合患者具体情况,并关注样本量限制对疗效判断的影响。
局限性
- 样本量相对较小,可能妨碍不同类固醇治疗方式有效性的区分。
- 研究为横断面设计,可能限制因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to describe patterns of corticosteroid treatment for sudden sensorineural hearing loss and to evaluate effectiveness based on delivery mode (oral vs intratympanic vs both). STUDY DESIGN: Cross-sectional repeated measures. SETTING: Patients were recruited from practices within the Creating Healthcare Excellence through Education and Research (CHEER) Network. CHEER is a National Institutes of Health-funded nationwide network of 30 community and academic otolaryngology practice sites. SUBJECTS AND METHODS: A subset of 117 patients who had been treated with steroids for sudden sensorineural hearing loss were recruited from within a larger initial CHEER Network study on clinical practice guideline compliance. Outcomes included audiometric and speech scores and patient-perceived improvement. Descriptive analyses, Wilcoxon rank-sum tests, and Fisher exact tests were run. RESULTS: Two categories (oral and simultaneous oral + intratympanic) had adequate sample sizes to support statistical comparison of treatment results. Improvements were seen in both audiometry and speech testing scores; 57% of patients self-reported improvement perceived as either minor or major. There were no significant differences in degree of improvement between these treatment groups. CONCLUSIONS: We observed that a majority of steroid-treated patients demonstrated hearing improvement, but this improvement did not meet criteria for statistical significance. As in other studies on this topic, the relatively small sample size may have prevented differentiation of effectiveness among steroid treatments. We propose that the use of alternative approaches, such as pragmatic clinical trials and multidisciplinary electronic health record systems and megadatabases, may hold the most promise for an approach to best practice development.
引用
- Witsell DL, Mulder H, Rauch S, et al. Steroid Use for Sudden Sensorineural Hearing Loss: A CHEER Network Study. Otolaryngol Head Neck Surg. 2018. PMID: 30084293. doi:10.1177/0194599818785142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。